NCT07120178 Imaging and Evolution of Pigmented Tumors of the Anterior Ocular System in Children
| NCT ID | NCT07120178 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Centre Hospitalier Universitaire de Saint Etienne |
| Condition | Pigmented Tumours of the Anterior Ocular System in Children |
| Study Type | OBSERVATIONAL |
| Enrollment | 53 participants |
| Start Date | 2025-04-01 |
| Primary Completion | 2025-12 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 53 participants in total. It began in 2025-04-01 with a primary completion date of 2025-12.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The investigators were interested in pigmented tumours of the anterior segment of the eye in children because there is very little data on their evolution. The nevus is the most common conjunctival tumour. The challenge is to be able to adapt the child's follow-up according to the imaging and avoid an invasive procedure such as surgical excision if the imaging does not find any suspicious cells despite a change in size or colour. This would also make it possible to answer parents' questions about the potential evolution of the tumour. Finally, it would enable the frequency of monitoring to be personalised according to the data analysed. The tests are all non-invasive and painless.
Eligibility Criteria
Inclusion Criteria: * Patient who had a first dermato-ophthalmological consultation \< 18 years old with pigmented tumors of the anterior ocular system Exclusion Criteria: * patient over 18 years old at first examination
Contact & Investigator
Jean Luc PERROT, Md, PhD
PRINCIPAL INVESTIGATOR
Centre Hospitalier Universitaire de Saint Etienne
Frequently Asked Questions
Who can join the NCT07120178 clinical trial?
This trial is open to participants of all sexes, up to 18 Years, studying Pigmented Tumours of the Anterior Ocular System in Children. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07120178 currently recruiting?
Yes, NCT07120178 is actively recruiting participants. Contact the research team at j.luc.perrot@chu-st-etienne.fr for enrollment information.
Where is the NCT07120178 trial being conducted?
This trial is being conducted at Saint-Etienne, France.
Who is sponsoring the NCT07120178 clinical trial?
NCT07120178 is sponsored by Centre Hospitalier Universitaire de Saint Etienne. The principal investigator is Jean Luc PERROT, Md, PhD at Centre Hospitalier Universitaire de Saint Etienne. The trial plans to enroll 53 participants.